Quest Diagnostics (DGX) return on invested capital (ROIC)

Return on invested capital · fiscal 2025
8.9%

Quest Diagnostics (DGX) earned a return on invested capital of 8.9% in fiscal 2025 (the year ended December 31, 2025). That is 1.1 percentage points higher than the 7.8% of fiscal 2024. Figures as of 18 Nov 2026, 02:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on invested capital, fiscal 2025
8.9%
Change on fiscal 2024
+1.1 pts
Highest on record
10.9%fiscal 2022
Lowest on record
7.8%fiscal 2024
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Quest Diagnostics return on invested capital (ROIC), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was 10.9% in fiscal 2022 and the lowest 7.8% in fiscal 2024. The fiscal 2025 figure is higher than in 67% of the 3 earlier fiscal years on record, whose median is 8.9%.

History · 4 fiscal years

Return on invested capital by fiscal year

Quest Diagnostics return on invested capital (ROIC), year by year

Quest Diagnostics (DGX) return on invested capital (ROIC) by fiscal year
Fiscal yearReturn on invested capitalChangeYear ended
20258.9% 1.1 pts up
20247.8% 1.1 pts down
20238.9% 2.0 pts down
202210.9%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

How to read it

It measures how well the business turns capital into profit whoever supplied it; a figure above the cost of that capital, roughly 8–10%, means growth creates value.

Return on invested capital at health care companies of similar size

Return on invested capital of Quest Diagnostics and comparable companies
CompanyReturn on invested capitalFiscal year
Labcorp Holdings LH8.2%2025
DexCom DXCM21.8%2025
Koninklijke Philips PHG6.9%2025
Roivant Sciences ROIV-296.1%2026
West Pharmaceutical Services WST18.8%2025
Quest Diagnostics DGX8.9%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DGX

Quest Diagnostics, figure by figure

Quest Diagnostics (DGX) overview: price, valuation and scorecardAll health care companies by market value

Quest Diagnostics return on invested capital (ROIC): questions and answers

What is Quest Diagnostics's return on invested capital?

Quest Diagnostics (DGX) earned a return on invested capital of 8.9% in fiscal 2025 (the year ended December 31, 2025). That is 1.1 percentage points higher than the 7.8% of fiscal 2024.

Is Quest Diagnostics's return on invested capital high or low compared with its own history?

The fiscal 2025 figure is higher than in 67% of the 3 earlier fiscal years on record, whose median is 8.9%.

What are the highest and lowest return on invested capital figures on record for Quest Diagnostics?

Across the 4 fiscal years on record (2022–2025), the highest was 10.9% in fiscal 2022 and the lowest 7.8% in fiscal 2024.

How is Quest Diagnostics's return on invested capital calculated?

Return on invested capital is operating income after tax divided by the capital in the business — debt plus equity minus cash — using the company's own tax rate where it is plausible and 21% otherwise, and shown only for the fiscal years in which cash is counted one way.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Quest Diagnostics (DGX) return on invested capital (ROIC)”, data as of 18 November 2026. https://funkfolio.com/stock/DGX/roic

Underlying data: the company's filings with the SEC and Yahoo Finance.